EGF c.787A>C ;(p.T263P)

Variant ID: 4-110866278-A-C

NM_001963.4(EGF):c.787A>C;(p.T263P)

This variant was identified in 6 publications

View GRCh38 version.




Publications:


Tyrosine Kinase Receptors in Oncology.

International Journal Of Molecular Sciences
Esteban-Villarrubia, Jorge J; Soto-Castillo, Juan José JJ; Pozas, Javier J; San Román-Gil, María M; Orejana-Martín, Inmaculada I; Torres-Jiménez, Javier J; Carrato, Alfredo A; Alonso-Gordoa, Teresa T; Molina-Cerrillo, Javier J
Publication Date: 2020-11-12

Variant appearance in text: EGF: T263P
PubMed Link: 33198314
Variant Present in the following documents:
  • Main text
  • ijms-21-08529.pdf
View BVdb publication page



Identification of potentially oncogenic alterations from tumor-only samples reveals Fanconi anemia pathway mutations in bladder carcinomas.

Npj Genomic Medicine
Madubata, Chioma J CJ; Roshan-Ghias, Alireza A; Chu, Timothy T; Resnick, Samuel S; Zhao, Junfei J; Arnes, Luis L; Wang, Jiguang J; Rabadan, Raul R
Publication Date: 2017

Variant appearance in text: EGF: T263P
PubMed Link: 29263839
Variant Present in the following documents:
  • 41525_2017_32_MOESM8_ESM.xlsx, sheet 3
View BVdb publication page



Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The "Rotation Model".

Cells
Purba, Endang R ER; Saita, Ei-Ichiro EI; Maruyama, Ichiro N IN
Publication Date: 2017-06-02

Variant appearance in text: EGF: T263P
PubMed Link: 28574446
Variant Present in the following documents:
  • Main text
  • cells-06-00013.pdf
View BVdb publication page



Genetic biomarkers of drug response for small-molecule therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in glioblastoma.

Cns Oncology
Venkatesan, Subramanian S; Lamfers, Martine L M ML; Dirven, Clemens M F CM; Leenstra, Sieger S
Publication Date: 2016

Variant appearance in text: EGF: T263P
PubMed Link: 26986934
Variant Present in the following documents:
  • Main text
View BVdb publication page



Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype.

Scientific Reports
Fu, Yong Y; Cruz-Monserrate, Zobeida Z; Helen Lin, H H; Chung, Yiyin Y; Ji, Baoan B; Lin, Szu-Min SM; Vonderfecht, Steven S; Logsdon, Craig D CD; Li, Chien-Feng CF; Ann, David K DK
Publication Date: 2015-08-20

Variant appearance in text: EGF: T263P
PubMed Link: 26289340
Variant Present in the following documents:
  • srep13347-s1.pdf
View BVdb publication page



Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.

Plos Medicine
Lee, Jeffrey C JC; Vivanco, Igor I; Beroukhim, Rameen R; Huang, Julie H Y JH; Feng, Whei L WL; DeBiasi, Ralph M RM; Yoshimoto, Koji K; King, Jennifer C JC; Nghiemphu, Phioanh P; Yuza, Yuki Y; Xu, Qing Q; Greulich, Heidi H; Thomas, Roman K RK; Paez, J Guillermo JG; Peck, Timothy C TC; Linhart, David J DJ; Glatt, Karen A KA; Getz, Gad G; Onofrio, Robert R; Ziaugra, Liuda L; Levine, Ross L RL; Gabriel, Stacey S; Kawaguchi, Tomohiro T; O'Neill, Keith K; Khan, Haumith H; Liau, Linda M LM; Nelson, Stanley F SF; Rao, P Nagesh PN; Mischel, Paul P; Pieper, Russell O RO; Cloughesy, Tim T; Leahy, Daniel J DJ; Sellers, William R WR; Sawyers, Charles L CL; Meyerson, Matthew M; Mellinghoff, Ingo K IK
Publication Date: 2006-12

Variant appearance in text: EGF: T263P
PubMed Link: 17177598
Variant Present in the following documents:
  • pmed.0030485.pdf
View BVdb publication page